WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
The production of guidelines for the management of drug-resistant tuberculosis (TB) fits the mandate of the World Health Organization (WHO) to support countries in the reinforcement of patient care. WHO commissioned external reviews to summarise evidence on priority questions regarding case-finding, treatment regimens for multidrug-resistant TB (MDR-TB), monitoring the response to MDR-TB treatment, and models of care. A multidisciplinary expert panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to develop recommendations. The recommendations support the wider use of rapid drug susceptibility testing for isoniazid and rifampicin or rifampicin alone using molecular techniques. Monitoring by sputum culture is important for early detection of failure during treatment. Regimens lasting ≥20 months and containing pyrazinamide, a fluoroquinolone, a second-line injectable drug, ethionamide (or prothionamide), and either cycloserine or p-aminosalicylic acid are recommended. The guidelines promote the early use of antiretroviral agents for TB patients with HIV on second-line drug regimens. Systems that primarily employ ambulatory models of care are recommended over others based mainly on hospitalisation. Scientific and medical associations should promote the recommendations among practitioners and public health decision makers involved in MDR-TB care. Controlled trials are needed to improve the quality of existing evidence, particularly on the optimal composition and duration of MDR-TB treatment regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationPharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Self-citationThe well-built clinical question: A key to evidence-based decisions
(1995) · ACP Journal Club · doi:10.7326/acpjc-1995-123-3-a12 · Cited by 2,931 · cited 2×
“This process was translated into the following seven specific questions, which were formulated using PICO (Population, Intervention, Comparator to the intervention, and Outcome) [10] or a similar format.”
BackgroundRapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 1×
“This is an important consideration given that access to Xpert MTB/RIF is expected to expand substantially in low resource countries(17).”
Background(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Going from evidence to recommendations
Guyatt, G. H., Oxman, A. D., Kunz, R., Falck-Ytter, Y., Vist, G. E., Liberati, A., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39493.646875.ae · Cited by 1,810
Self-citationGandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Global Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Anti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Van Deun, A., Maug, A. K. J., Salim, M. A. H., Das, P. K., Sarker, M. R., Daru, P., & Rieder, H. L. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0077oc · Cited by 647
Orenstein, E. W., Basu, S., Shah, N. S., Andrews, J. R., Friedland, G. H., Moll, A. P., Gandhi, N. R., & Galvani, A. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70041-6 · Cited by 540
Accelerated course of human immunodeficiency virus infection after tuberculosis.
Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff, M., & Ellner, J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.1.7812542 · Cited by 535
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Self-citationHIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
Wells, C. D., Cegielski, J. P., Nelson, L. J., Laserson, K. F., Holtz, T. H., Finlay, A., Castro, K. G., & Weyer, K. (2007) · The Journal of Infectious Diseases · doi:10.1086/518665 · Cited by 483
Self-citationDybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., & Pau, A. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00001 · Cited by 482
Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055524 · Cited by 468
International standards of tuberculosis care.
Mohan, A. (2006) · PubMed · Cited by 432
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
Johnston, J. C., Shahidi, N. C., Sadatsafavi, M., & Fitzgerald, J. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006914 · Cited by 412
Multidrug-resistant Tuberculosis
Dooley, S. W., Jarvis, W. R., Marione, W. J., & Snider, D. E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-257 · Cited by 376
Global Tuberculosis Programme, & Disease, L. (1997) · Medical Entomology and Zoology · Cited by 361
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
Dean, G. L., Edwards, S. G., Ives, N. J., Matthews, G., Fox, E. F., Navaratne, L., Fisher, M., Taylor, G. P., Miller, R., Taylor, C. B., et al. (2002) · AIDS · doi:10.1097/00002030-200201040-00010 · Cited by 354
Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2007) · AIDS · doi:10.1097/qad.0b013e328011efac · Cited by 343
Carter, T. (2003) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.1021 · Cited by 343
Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs
Barrera, L. Y. B., Cooreman, E., Iragena, J. D. D., Drobniewski, F. A., Duda, P. W., Havelková, M., Hoffner, S. E., Km, K., Kim, S. J., Labelle, S., et al. (2008) · Cited by 328
Self-citationGraham, S. M. (2007) · Europe PMC (PubMed Central) · Cited by 328
Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.
Laserson, K. F., Thorpe, L. E., Leimane, V., Weyer, K., Mitnick, C. D., Riekstiņa, V., Zarovska, E., Rich, M., Fraser, H., Alarcon, E., et al. (2005) · PubMed · Cited by 314
Self-citationProportion of tuberculosis transmission that takes place in households in a high-incidence area
Verver, S., Warren, R. M., Munch, Z., Richardson, M., van der Spuy, G. D., Borgdorff, M. W., Behr, M. A., Beyers, N., & van Helden, P. D. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15332-9 · Cited by 301
Tuberculosis in patients with the acquired immunodeficiency syndrome
Richard, R. (1987) · Medical Entomology and Zoology · Cited by 297
Mitchison, D. A. (1998) · PubMed · Cited by 288
GUIDELINES FOR SURVEILLANCE OF DRUG RESISTANCE IN TUBERCULOSIS
Aziz, M. A., Laszlo, A., Raviglione, M. C., Rieder, H. L., Espinal, M., Wright, A., & Davenport, J. (2003) · Cited by 287
Self-citationDrug-susceptibility testing in tuberculosis: methods and reliability of results
Kim, S. J. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00111304 · Cited by 285
Leimane, V., Riekstina, V., Holtz, T. H., Zarovska, E., Skripconoka, V., Thorpe, L. E., Laserson, K. F., & Wells, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17786-1 · Cited by 279
Self-citationGuidelines for the Management of Drug-resistant Tuberculosis
Crofton, S. J., Chaulet, P., Maher, D., Grosset, J. H. E., Harris, W. T., Horne, N., Iseman, M. D., & Watt, B. (1997) · Cited by 270
Global Tuberculosis Control: WHO Report 2011
Williams, C. (2012) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2012.00928.x · Cited by 265
WHO Expert Committee on Specifications for Pharmaceutical Preparations.
Yin, H., Hetzke, J., Kozarewicz, P., Gould, A., Vallender, M., Suffolk, B., Hoek, A., Addae‐Mensah, I., Mehmandoust, M., Rabouhans, M. L., et al. (1969) · PubMed · Cited by 261
Adjunctive Corticosteroid Therapy for Tuberculosis: A Critical Reappraisal of the Literature
Dooley, D. P., Carpenter, J. L., & Rademacher, S. (1997) · Clinical Infectious Diseases · doi:10.1086/515543 · Cited by 259
Fischl, M. A., Daikos, G. L., Uttamchandani, R. B., Poblete, R. B., Moreno, J. N., Reyes, R. R., Boota, A. M., Thompson, L. M., Cleary, T. J., Oldham, S. A., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-184 · Cited by 248
Dheda, K., Shean, K., Zumla, A., Badri, M., Streicher, E. M., Page-Shipp, L., Willcox, P., John, M.-A., Reubenson, G., Govindasamy, D., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60492-8 · Cited by 246
Williams, D. L., Spring, L., Collins, L., Miller, L. P., Heifets, L. B., Gangadharam, P. R. J., & Gillis, T. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1853 · Cited by 236
Antimicrobial Therapy and Vaccines
Weber (2002) · Cited by 234
Nathanson, E., Gupta, R., Huamani, P., Leimane, V., Pasechnikov, A., Tupasi, T. E., Vink, K., Jaramillo, E., & Espinal, M. (2004) · PubMed · Cited by 229
Self-citationInterim policy on collaborative TB / HIV activities.
Getahun, H., van Gorkom, J., Harries, A. D., Harrington, M., & Nunn, P. (2004) · Cited by 227
Self-citationMcIlleron, H., Meintjes, G., Burman, W. J., & Maartens, G. (2007) · The Journal of Infectious Diseases · doi:10.1086/518655 · Cited by 226
Suárez, P. G., Floyd, K., Portocarrero, J., Alarcón, E., Rapiti, E., Ramos, G., Bonilla, C., Sabogal, I., Aranda, I., Dye, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08830-x · Cited by 211
Self-citationPresent aspects of bacterial resistance in tuberculosis.
Canetti, G. (1965) · PubMed · doi:10.1164/arrd.1965.92.5.687 · Cited by 211
Harries, A. D., Maher, D., & Graham, S. M. (2004) · Cited by 194
Fitzpatrick, C., & Floyd, K. (2012) · PharmacoEconomics · doi:10.2165/11595340-000000000-00000 · Cited by 186
Self-citationRight to the highest attainable standard of health
Hunt, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61173-8 · Cited by 182
Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug Resistance
Cox, H. S., Kebede, Y. N., Allamuratova, S., Ismailov, G., Davletmuratova, Z., Byrnes, G. B., Stone, C., Niemann, S., Rüsch–Gerdes, S., Blok, L., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030384 · Cited by 178
Self-citationHoffmann, C. J., Charalambous, S., Thio, C. L., Martin, D. J., Pemba, L., Fielding, K. L., Churchyard, G. J., Chaisson, R. E., & Grant, A. D. (2007) · AIDS · doi:10.1097/qad.0b013e32814e6b08 · Cited by 172
Suárez, Floyd, Portocarrero, & Alarcon (2002) · The Lancet · Cited by 166
Furin, J. J., Mitnick, C. D., Shin, S. S., Bayona, J. N., Becerra, M. C., Singler, J. M., de Alcântara, F. F., Castañieda, C., Sanchez, E., Acha, J., et al. (2001) · PubMed · Cited by 159
Self-citationNavas, E., Martín‐Dávila, P., Moreno, L., Pintado, V., Casado, J. L., Fortún, J., Pérez-Elías, M. J., Gomez-Mampaso, E., & Moreno, S. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.1.97 · Cited by 151
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
Eker, B., Ortmann, J., Migliori, G. B., Sotgiu, G., Mütterlein, R., Centis, R., Hoffmann, H., Kirsten, D. K., Schaberg, T., Ruesch-Gerdes, S., et al. (2008) · Emerging infectious diseases · doi:10.3201/eid1411.080729 · Cited by 151
Self-citationTransmission of Tuberculosis to Close Contacts of Patients With Multidrug-Resistant Tuberculosis
Kritski, A. L., Marques, M. J., Rabahi, M. F., Vieira, M. A. M. S., Werneck-Barroso, E., Carvalho, C. E., Andrade, G. D. N., Bravo-de-Souza, R., Andrade, L. M., Gontijo, P. P., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.1.8542139 · Cited by 148
Improved Outcomes for Patients with Multidrug-Resistant Tuberculosis
Turett, G. S., Telzak, E. E., Torian, L. V., Blum, S., Alland, D., Weisfuse, I. B., & Fazal, B. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1238 · Cited by 144
Tupasi, T. E., Gupta, R., Quelapio, M. I. D., Orillaza-Chi, R., Mira, N. R. C., Mangubat, N. V., Belen, V., Arnisto, N., Macalintal, L., Arabit, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030352 · Cited by 129
Self-citationGuidelines For The Treatment Of Tuberculosis
Ravindran, P., Madhu, K., & Arjun, P. (2001) · Lung India · Cited by 112
Holtz, T. H., Lancaster, J., Laserson, K. F., Wells, C. D., Thorpe, L. E., & Weyer, K. (2006) · PubMed · Cited by 101
Self-citationRetreatment Tuberculosis Cases
Kritski, A. L., de Jesus, L. S. R., Werneck-Barroso, E., Vieira, M. A. M. S., Andrade, M. K. D. N., de Jesus, L. S. R., Werneck-Barroso, E., Vieira, M. A. M. S., Andrade, M. K. D. N., Haffner, A., et al. (1997) · CHEST Journal · doi:10.1378/chest.111.5.1162 · Cited by 97
Shean, K., Willcox, P. A., Siwendu, S., Laserson, K. F., Gross, L., Kammerer, S., Wells, C. D., & Holtz, T. H. (2008) · PubMed · Cited by 85
Self-citationTuberculosis control in prisons : a manual for programme managers
Bone, A., Aerts, A., Grzemska, M., Kimerling, M., Kluge, H. H. P., Levy, M., Portaels, F., Raviglione, M. C., & Varaine, F. (2000) · Cited by 80
Self-citationCost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
Dowdy, D. W., O'Brien, M. A., & Bishai, D. M. (2008) · PubMed · Cited by 73
(1999) · PubMed · Cited by 71
Dowdy, D. W., Lourenço, M. C. S., Cavalcante, S. C., Saraceni, V., King, B., Golub, J. E., Bishai, D. M., Durovni, B., Chaisson, R. E., & Dorman, S. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004057 · Cited by 67
Padilla‐Zakour, O. I. (2008) · Wiley eBooks · doi:10.1002/9780470439074.ch20 · Cited by 67
Fluoroquinolones for treating tuberculosis
Зиганшина, Л. Е., Vizel, A., & Squire, S. B. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004795.pub2 · Cited by 65
Varma, J. K., Nateniyom, S., Akksilp, S., Mankatitham, W., Sirinak, C., Sattayawuthipong, W., Burapat, C., Kittikraisak, W., Monkongdee, P., Cain, K. P., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-42 · Cited by 64
Fluoroquinolones for treating tuberculosis
Зиганшина, Л. Е., & Squire, S. B. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004795.pub3 · Cited by 64
Kim, J. Y., Mukherjee, J. S., Rich, M., Mate, K. S., Bayona, J. N., & Becerra, M. C. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00078-1 · Cited by 59
Self-citationScaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda
Cobelens, F. G. J., Heldal, E., Kimerling, M. E., Mitnick, C. D., Podewils, L. J., Ramachandran, R., Rieder, H. L., Weyer, K., Zignol, M., & on behalf of the Working Group on MDR-TB of the Stop TB Partnership (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050150 · Cited by 55
Self-citationClinical Pharmacology and Therapeutic Drug Monitoring in Neonates and Children
Loebstein, R., & Koren, G. (1998) · Pediatrics in Review · doi:10.1542/pir.19-12-423 · Cited by 52
Drug-Resistant Tuberculosis in Pediatrics
Swanson, D. S., & Starke, J. R. (1995) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38979-9 · Cited by 51
THE MATERNAL AND FETAL EFFECTS OF TUBERCULOSIS THERAPY
Brost, B. C., & Newman, R. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70329-6 · Cited by 49
Pachas, A. M. C., Blank, R., Fawzi, M. C. S., Bayona, J. N., Becerra, M. C., & Mitnick, C. D. (2004) · PubMed · Cited by 48
Self-citationLee, H., Cho, S.-N., Bang, H. E., Lee, J. H., Bai, G. H., Kim, S. J., & Kim, J. D. (2000) · PubMed · Cited by 46
Blanc, F. –., Thim, S., Laureillard, D., Borand, L., Rekacewicz, C., Nerrienet, E., Madec, Y., Marcy, O., Chan, S., Prak, N., et al. (2011) · BMC Proceedings · doi:10.1186/1753-6561-5-s1-o11 · Cited by 38
Mycobacterium tuberculosis Complex
Globan, M., & Fyfe, J. (2010) · Springer eBooks · doi:10.1007/978-90-481-9039-3_18 · Cited by 36
Tuberculosis control in prisons.
Kendig, N. E. (1998) · PubMed · Cited by 36
ANTIBIOTIC SELECTION IN OBSTETRIC PATIENTS
Duff, P. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70338-x · Cited by 35
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Oxlade, O., Falzon, D., & Menzies, D. (2011) · European Respiratory Journal · doi:10.1183/09031936.00065311 · Cited by 33
Self-citationGuidelines for implementing collaborative TB and HIV programme activities.
Hargreaves, N. J., & Scano, F. (2003) · Cited by 31
Responsibility and Accountability
(2017) · University of Arkansas Press eBooks · doi:10.2307/j.ctt1ffjg95.8 · Cited by 26
Akçakir, Y. (2010) · eScholarship@McGill (McGill) · doi:10.82308/22209 · Cited by 26
Community Based Care: The New Health Social Work Paradigm
Simmons, W. J. (1994) · Social Work in Health Care · doi:10.1300/j010v20n01_06 · Cited by 22
AZT (Zidovudine) Just a Step Away From FDA Approval for AIDS Therapy
Marwick, C. S. (1987) · JAMA · doi:10.1001/jama.1987.03390100015002 · Cited by 8
Cited by
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017863 · Cited by 805
Self-citationTowards tuberculosis elimination: an action framework for low-incidence countries
Lönnroth, K., Migliori, G. B., Abubakar, I., D'Ambrosio, L., de Vries, G., Diel, R., Douglas, P., Falzon, D., Gaudreau, M.-A., Goletti, D., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00214014 · Cited by 778
Self-citationZumla, A., Raviglione, M., Hafner, R., & Fordham von Reyn, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1200894 · Cited by 698
Self-citation
Metadata
- Authors
- Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., Fitzpatrick, C., Gebhard, A., Getahun, H., Henkens, M., Holtz, T. H., Keravec, J., Keshavjee, S., Khan, A. J., Kulier, R., Leimane, V., Lienhardt, C., Lu, C., Mariandyshev, A., Migliori, G. B., Mirzayev, F., Mitnick, C. D., Nunn, P., Nwagboniwe, G., Oxlade, O., Palmero, D., Pavlinac, P., Quelapio, M. I., Raviglione, M. C., Rich, M. L., Royce, S., Rüsch-Gerdes, S., Salakaia, A., Sarin, R., Sculier, D., Varaine, F., Vitoria, M., Walson, J. L., Wares, F., Weyer, K., White, R. A., & Zignol, M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2011-08-02
- Volume
- 38
- Issue
- 3
- Pages
- 516-528
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2135027892
- Cited by
- 1,100
- References
- 89
- FWCI
- 78.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.